1. Antihypertensive effect of Mali-Nil surin rice bran hydrolysate and its mechanisms related to the EDHF-mediated vasorelaxation and L-type Ca 2+ channel-mediated vasoconstriction in L-NAME hypertensive rats.
- Author
-
Pannangpetch P, Tangsucharit P, Thanaruksa R, Proongkhong T, Srisuwan S, and Aekthammarat D
- Subjects
- Animals, Antihypertensive Agents adverse effects, Antioxidants pharmacology, Biological Factors, Blood Pressure, Male, Mali, NG-Nitroarginine Methyl Ester pharmacology, Nitric Oxide metabolism, Rats, Thailand, Vasoconstriction, Vasodilation, Hypertension chemically induced, Hypertension drug therapy, Hypertension metabolism, Oryza
- Abstract
Mali-Nil Surin rice bran hydrolysate (MRH) contains highly nutritional proteins and beneficial phenolic compounds. This study investigated an antihypertensive effect of MRH and evaluated the mechanisms mediating this action in N
ω -nitro-L-arginine-methyl ester (L-NAME)-induced hypertensive rats. Antihypertensive activity was determined in male rats orally administered with MRH (100 or 300 mg/kg) or enalapril (15 mg/kg) daily together with L-NAME (50 mg/kg/day) in drinking water, for 21 days. Concurrent oral treatment with MRH lowered the high blood pressure in the L-NAME-induced hypertensive rats. MRH treatment improved endothelial function and increased the endothelium-derived hyperpolarizing factor-mediated vasorelaxation in L-NAME hypertensive rats. L-NAME rats treated with MRH had reduced adrenergic hypercontractility, which was associated with a decrease in L-type calcium channel-mediated vasoconstriction. In addition, MRH exhibited antioxidant activity in hypertensive rats, as indicated by suppression of vascular superoxide anion production and reduction of malondialdehyde levels, as well as magnification of superoxide dismutase and catalase activities in serum. This study demonstrated the nutraceutical potential of MRH to prevent oxidative stress-related vascular dysfunction in hypertension., (Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF